US Stock MarketDetailed Quotes

CervoMed (CRVO)

Watchlist
  • 3.110
  • -0.030-0.96%
Close May 29 16:00 ET
  • 3.110
  • 0.0000.00%
Post 16:10 ET
28.79MMarket Cap-0.95P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CervoMed (CRVO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
52.95%8.11M
55.23%28.29M
15.06%8.33M
49.07%8.04M
120.90%6.62M
104.35%5.3M
133.30%18.23M
191.92%7.24M
101.72%5.4M
143.31%3M
Selling and administrative expenses
24.87%2.98M
14.37%10.48M
8.37%2.51M
5.22%2.33M
30.01%3.27M
11.97%2.38M
40.61%9.17M
9.48%2.32M
-8.27%2.21M
153.05%2.51M
-General and administrative expense
24.87%2.98M
14.37%10.48M
8.37%2.51M
5.22%2.33M
30.01%3.27M
11.97%2.38M
40.61%9.17M
9.48%2.32M
-8.27%2.21M
153.05%2.51M
Research and development costs
6.15%5.14M
16.06%21.82M
-17.73%5.83M
17.86%6.04M
35.42%5.11M
71.90%4.84M
122.77%18.8M
148.19%7.09M
186.08%5.13M
92.63%3.77M
Other operating expenses
----
58.86%-4.01M
99.60%-8.73K
83.37%-322.57K
46.56%-1.76M
18.31%-1.92M
-36.29%-9.74M
13.19%-2.16M
-27.07%-1.94M
-91.23%-3.29M
Operating profit
-52.95%-8.11M
-55.23%-28.29M
-15.06%-8.33M
-49.07%-8.04M
-120.90%-6.62M
-104.35%-5.3M
-133.30%-18.23M
-191.92%-7.24M
-101.72%-5.4M
-143.31%-3M
Net non-operating interest income expense
-63.96%147.39K
-31.00%1.34M
-54.73%240.94K
-50.67%318.79K
-45.74%368.13K
407.22%408.99K
782.94%1.94M
348.52%532.18K
1,255.60%646.17K
3,731.48%678.44K
Non-operating interest income
-63.96%147.39K
-31.00%1.34M
-54.73%240.94K
-50.67%318.79K
-45.74%368.13K
407.22%408.99K
782.94%1.94M
348.52%532.18K
1,255.60%646.17K
3,731.48%678.44K
Other net income (expense)
-656.30%-1.02K
-740.26%-8.33K
20.73%3.29K
64.33%-1.23K
-4,052.23%-10.26K
-350.00%-135
-100.02%-991
554.33%2.73K
-100.07%-3.44K
99.88%-247
Other non- operating income (expenses)
-656.30%-1.02K
-740.26%-8.33K
20.73%3.29K
64.33%-1.23K
-4,052.23%-10.26K
-350.00%-135
-100.02%-991
554.33%2.73K
-100.07%-3.44K
99.88%-247
Income before tax
-62.73%-7.96M
-65.53%-26.97M
-20.60%-8.09M
-62.54%-7.73M
-170.12%-6.26M
-94.65%-4.89M
-650.08%-16.29M
-183.86%-6.71M
-321.06%-4.75M
-62.53%-2.32M
Income tax
Net income
-62.73%-7.96M
-65.53%-26.97M
-20.60%-8.09M
-62.54%-7.73M
-170.12%-6.26M
-94.65%-4.89M
-650.08%-16.29M
-183.86%-6.71M
-321.06%-4.75M
-62.53%-2.32M
Net income continuous Operations
-62.73%-7.96M
-65.53%-26.97M
-20.60%-8.09M
-62.54%-7.73M
-170.12%-6.26M
-94.65%-4.89M
-650.08%-16.29M
-183.86%-6.71M
-321.06%-4.75M
-62.53%-2.32M
Minority interest income
Net income attributable to the parent company
-62.73%-7.96M
-65.53%-26.97M
-20.60%-8.09M
-62.54%-7.73M
-170.12%-6.26M
-94.65%-4.89M
-650.08%-16.29M
-183.86%-6.71M
-321.06%-4.75M
-62.53%-2.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-62.73%-7.96M
-65.53%-26.97M
-20.60%-8.09M
-62.54%-7.73M
-170.12%-6.26M
-94.65%-4.89M
-650.08%-16.29M
-183.86%-6.71M
-321.06%-4.75M
-62.53%-2.32M
Basic earnings per share
-53.57%-0.86
-47.52%-2.98
-10.00%-0.88
-52.73%-0.84
-159.26%-0.7
-36.59%-0.56
-146.34%-2.02
-92.16%-0.8
-184.62%-0.55
90.18%-0.27
Diluted earnings per share
-53.57%-0.86
-47.52%-2.98
-10.00%-0.88
-52.73%-0.84
-159.26%-0.7
-36.59%-0.56
-146.34%-2.02
-92.16%-0.8
21.43%-0.55
90.18%-0.27
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 52.95%8.11M55.23%28.29M15.06%8.33M49.07%8.04M120.90%6.62M104.35%5.3M133.30%18.23M191.92%7.24M101.72%5.4M143.31%3M
Selling and administrative expenses 24.87%2.98M14.37%10.48M8.37%2.51M5.22%2.33M30.01%3.27M11.97%2.38M40.61%9.17M9.48%2.32M-8.27%2.21M153.05%2.51M
-General and administrative expense 24.87%2.98M14.37%10.48M8.37%2.51M5.22%2.33M30.01%3.27M11.97%2.38M40.61%9.17M9.48%2.32M-8.27%2.21M153.05%2.51M
Research and development costs 6.15%5.14M16.06%21.82M-17.73%5.83M17.86%6.04M35.42%5.11M71.90%4.84M122.77%18.8M148.19%7.09M186.08%5.13M92.63%3.77M
Other operating expenses ----58.86%-4.01M99.60%-8.73K83.37%-322.57K46.56%-1.76M18.31%-1.92M-36.29%-9.74M13.19%-2.16M-27.07%-1.94M-91.23%-3.29M
Operating profit -52.95%-8.11M-55.23%-28.29M-15.06%-8.33M-49.07%-8.04M-120.90%-6.62M-104.35%-5.3M-133.30%-18.23M-191.92%-7.24M-101.72%-5.4M-143.31%-3M
Net non-operating interest income expense -63.96%147.39K-31.00%1.34M-54.73%240.94K-50.67%318.79K-45.74%368.13K407.22%408.99K782.94%1.94M348.52%532.18K1,255.60%646.17K3,731.48%678.44K
Non-operating interest income -63.96%147.39K-31.00%1.34M-54.73%240.94K-50.67%318.79K-45.74%368.13K407.22%408.99K782.94%1.94M348.52%532.18K1,255.60%646.17K3,731.48%678.44K
Other net income (expense) -656.30%-1.02K-740.26%-8.33K20.73%3.29K64.33%-1.23K-4,052.23%-10.26K-350.00%-135-100.02%-991554.33%2.73K-100.07%-3.44K99.88%-247
Other non- operating income (expenses) -656.30%-1.02K-740.26%-8.33K20.73%3.29K64.33%-1.23K-4,052.23%-10.26K-350.00%-135-100.02%-991554.33%2.73K-100.07%-3.44K99.88%-247
Income before tax -62.73%-7.96M-65.53%-26.97M-20.60%-8.09M-62.54%-7.73M-170.12%-6.26M-94.65%-4.89M-650.08%-16.29M-183.86%-6.71M-321.06%-4.75M-62.53%-2.32M
Income tax
Net income -62.73%-7.96M-65.53%-26.97M-20.60%-8.09M-62.54%-7.73M-170.12%-6.26M-94.65%-4.89M-650.08%-16.29M-183.86%-6.71M-321.06%-4.75M-62.53%-2.32M
Net income continuous Operations -62.73%-7.96M-65.53%-26.97M-20.60%-8.09M-62.54%-7.73M-170.12%-6.26M-94.65%-4.89M-650.08%-16.29M-183.86%-6.71M-321.06%-4.75M-62.53%-2.32M
Minority interest income
Net income attributable to the parent company -62.73%-7.96M-65.53%-26.97M-20.60%-8.09M-62.54%-7.73M-170.12%-6.26M-94.65%-4.89M-650.08%-16.29M-183.86%-6.71M-321.06%-4.75M-62.53%-2.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -62.73%-7.96M-65.53%-26.97M-20.60%-8.09M-62.54%-7.73M-170.12%-6.26M-94.65%-4.89M-650.08%-16.29M-183.86%-6.71M-321.06%-4.75M-62.53%-2.32M
Basic earnings per share -53.57%-0.86-47.52%-2.98-10.00%-0.88-52.73%-0.84-159.26%-0.7-36.59%-0.56-146.34%-2.02-92.16%-0.8-184.62%-0.5590.18%-0.27
Diluted earnings per share -53.57%-0.86-47.52%-2.98-10.00%-0.88-52.73%-0.84-159.26%-0.7-36.59%-0.56-146.34%-2.02-92.16%-0.821.43%-0.5590.18%-0.27
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +10.75%
Sample Name
Sample Code
 +4.76%
Sample Name
Sample Code
 -3.88%
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
-5.50%
5
VanEck Oil Services ETF
OIH
-6.69%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +30.10%
Sample Name
Sample Code
 +27.98%
Sample Name
Sample Code
 +20.87%
4
ASE Technology
ASX
+17.49%
5
Pony AI
PONY
+12.32%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 29, Eastern Time, Trump held a two-hour meeting in the White House Situation Room but has not yet reached a final decision on negotia Show More
Options Sir on Macro | Big Week Ahead! US-Iran Deal May Materialize + PCE Data Looms—How to Navigate Markets Next?
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

- No more -